Pine Valley Investments LTD Liability CO Regeneron Pharmaceuticals, Inc. Transaction History
Pine Valley Investments LTD Liability CO
- $1.53 Trillion
- Q2 2024
A detailed history of Pine Valley Investments LTD Liability CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pine Valley Investments LTD Liability CO holds 4,455 shares of REGN stock, worth $4.13 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
4,455
Previous 3,829
16.35%
Holding current value
$4.13 Million
Previous $3.69 Billion
27.05%
% of portfolio
0.31%
Previous 0.25%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,482Shares Held
85.5MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.34 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.83 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$7.68 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.49 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.3 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $99.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...